Business Context and Reporting Period
The Gorman-Rupp Company filed its Form 10-Q for the nine-month period ended September 30, 1995. The company, incorporated in Ohio, manufactures pumps and related equipment. The financial statements are unaudited and reflect a 3-for-2 stock split effective October 27, 1994.
Key Financial Metrics
| Metric | Nine Months Ended Sep 30, 1995 | Nine Months Ended Sep 30, 1994 |
|---|---|---|
| Net Sales | $112,300,000 | $105,902,000 |
| Net Income | $7,180,000 | $7,912,000 |
| Net Income Per Share | $0.84 | $0.92 |
| Operating Cash Flow | $9,850,000 | $11,528,000 |
| Cash and Cash Equivalents (End of Period) | $2,204,000 | $2,727,000 |
| Total Debt (Current + Long Term) | $6,984,000 | $8,215,000 |
| Current Ratio | 3.0 to 1 | 3.7 to 1 (Dec 31, 1994) |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 6.0% year-over-year, driven primarily by increased sales at the Mansfield Division.
- Profitability Decline: Despite higher sales, net income decreased 9.3% ($732,000). Net income margin dropped from 7.5% to 6.4%.
- Cost Pressures: Cost of products sold as a percentage of net sales rose from 73.6% to 75.3%. Management attributed this to product mix changes, increased material costs, and higher medical insurance expenses.
- Expense Increases: Selling, general, and administrative expenses rose 6.8%, driven by higher consulting fees and wages.
- Liquidity: Cash and cash equivalents decreased by $523,000 during the period. The current ratio declined from 3.7 to 3.0.
Outlook, Risks, and Management Commentary
Management stated that the company maintains adequate working capital, borrowing capacity, and a healthy liquidity position. Capital expenditures and working capital are primarily financed through internally generated funds and bank financing. No specific forward-looking guidance or quantitative outlook was provided in this filing. The filing notes that interim results are not necessarily indicative of full-year results.
Investor Verification Checklist
- Verify the sustainability of the 6.0% sales growth given the concurrent decline in net income margins.
- Assess the impact of rising medical insurance costs and product mix changes on future gross margins.
- Monitor the trend in operating cash flow, which decreased by approximately $1.7 million compared to the prior year.
- Review the company's ability to maintain liquidity as the current ratio tightens from 3.7 to 3.0.
- Confirm the status of the postretirement health benefits obligation, which stands at $23.4 million.